The Social Security Administration has requested the National Academies of Sciences, Engineering, and Medicine to review the latest published research and science and produce a report addressing best ...

Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, today highlighted t ...

The gut bacteria B. adolescentis eased lung scarring in a pulmonary fibrosis mouse model, showing potential as a preventive ...

Courtney Southwick is a writer focusing on health, nutrition, and disease. She has been blogging for the past two years at CourtneySouthwick.com. She writes blogs and articles for online publications ...

Implementing Deep Inspiration Breath-Hold (DIBH) for Left-Sided Breast Cancer Radiotherapy at the Anbar Cancer Center, Iraq: ...

Background Annually, 4% of the global population undergoes non-cardiac surgery, with 30% of those patients having at least ...

KT-621 BROADEN2 Phase 2b trial in AD ongoing, with data expected by mid-2027KT-621 BREADTH Phase 2b trial in asthma initiated, with data expected ...

Background Up to half of patients with infective endocarditis (IE) require cardiac surgery. Although anaemia is common, its ...

Background Ebstein’s anomaly (EA) exhibits significant anatomical and clinical heterogeneity, warranting a systematic ...

Travere Therapeutics, Inc., announced that today the U.S. Food and Drug Administration (FDA) has extended the review timeline of its supplemental New Drug Application (sNDA) for FILSPARI® (sparsentan) ...

Despite incredible strides taken in cancer medicine over past decades, many patients endure a prolonged journey of trial and error, searching for the treatment that fits their unique needs. Cancer ...

FY 2025 Preliminary Unaudited Total Revenue of Approximately $510–511 Million Meets or Exceeds Prior Guidance. Previously Provided FY 2025 Adjusted EBITDA (1) and Adjusted Net I ...